Faculty Presentations




Tanja Diana, PhD |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
AITD
Fig. 04 -
TBAb
Fig. 05 -
Potential Indications
Fig. 06 -
Bioassays
Fig. 07 -
Mutant Chimeric
Fig. 08 -
Protocol
Fig. 09 -
Linear Ranges
Fig. 10 -
Comparison
Fig. 11 -
Blocking Activity
Fig. 12 -
K1-70 mAb
Fig. 13 -
Different Ratios A
Fig. 14 -
Different Ratios B
Fig. 15 -
Correlation
Fig. 16 -
Analytic Performance
Fig. 17 -
Intra-assay Precision
Fig. 18 -
K1-70 mAb concentrations
Fig. 19 -
Precision Data
Fig. 20 -
Interference
Fig. 21 -
Thyroid Function
Fig. 22 -
Distribution
Fig. 23 -
Classification
Fig. 24 -
Binding Assay Results
Fig. 25 -
Summary
Fig. 26 -
Conclusions
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.